Categories: HealthcareNews

Avantor® to Participate in the 43rd Annual J.P. Morgan Healthcare Conference

RADNOR, Pa., Jan. 3, 2025 /PRNewswire/ — Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and advanced technology industries, announced that Michael Stubblefield, President and CEO, will present at the 43rd Annual J.P. Morgan Healthcare Conference at The Westin St. Francis Hotel in San Francisco on Wednesday, January 15, 2025 at approximately 8:15 a.m. Pacific Standard Time.

To hear a live audio webcast of the session, visit Events & Presentations in the Investor section of Avantor’s website, ir.avantorsciences.com. A replay of the webcast will be available for 30 days.

About Avantor
Avantor® is a leading life science tools company and global provider of mission-critical products and services to the life sciences and advanced technology industries. We work side-by-side with customers at every step of the scientific journey to enable breakthroughs in medicine, healthcare, and technology. Our portfolio is used in virtually every stage of the most important research, development and production activities at more than 300,000 customer locations in 180 countries. For more information, visit avantorsciences.com and find us on LinkedInX (Twitter) and Facebook.

Investor Relations Contact
Christina Jones
Vice President, Investor Relations
Avantor
805-617-5297
Christina.Jones@avantorsciences.com

Global Media Contact
Eric Van Zanten
Head of External Communications
Avantor
610-529-6219
Eric.VanZanten@avantorsciences.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/avantor-to-participate-in-the-43rd-annual-jp-morgan-healthcare-conference-302341283.html

SOURCE Avantor and Financial News

Staff

Recent Posts

Jacksonville Medical Care and Cabot Medical Care Notify Individuals of Data Security Incident

JACKSONVILLE, Ark., April 10, 2025 /PRNewswire/ -- Jacksonville Medical Care ("JMC") and Cabot Medical Care…

32 minutes ago

Oncolytics Biotech® Funds Pelareorep’s Ongoing Clinical Development with a Share Purchase Agreement in Partnership with Alumni Capital

SAN DIEGO and CALGARY, AB, April 10, 2025 /PRNewswire/ -- Oncolytics Biotech® Inc. (NASDAQ: ONCY) (TSX:…

32 minutes ago

Alabama Ophthalmology Associates Provides Notice Following Data Security Incident

BIRMINGHAM, Ala., April 10, 2025 /PRNewswire/ -- Alabama Ophthalmology Associates ("AOA") experienced a data security…

32 minutes ago

cbdMD, Inc. Announces Shareholder Approval of Automatic Conversion of Series A Preferred Stock and Other Results from Annual Meeting

Charlotte, North Carolina--(Newsfile Corp. - April 10, 2025) - cbdMD, Inc. (NYSE American: YCBD) (NYSE…

7 hours ago

Laboratory Services Cooperative Notifies Individuals of Security Incident

SEATTLE, April 10, 2025 /PRNewswire/ -- Laboratory Services Cooperative (LSC), a non-profit organization based in…

7 hours ago

True Dental Care Provides Notice of Data Incident

SUWANEE, Ga., April 10, 2025 /PRNewswire/ -- On February 3, 2025, True Dental Care ("True…

7 hours ago